ALKS vs WELL · P/E 14, rev $1.56B vs P/E 100, rev $10.84B
Alkermes Plc (ALKS) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the ALKS and WELL stock pages for the full models.
Not investment advice.